Biospecifics Tech Cp (BSTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 01-2000 | 12-1999 | 09-1999 | 06-1999 | 03-1999 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | 3,830 | 5,630 | 3,870 | 5,080 |
| Marketable Securities | N/A | 1,090 | 860 | 2,760 | 2,100 |
| Receivables | N/A | 2,170 | 1,100 | 1,150 | 1,200 |
| Inventories | N/A | 1,640 | 1,510 | 1,550 | 1,480 |
| Other current assets | 0 | 1,290 | 1,250 | 780 | 570 |
| TOTAL | $N/A | $10,020 | $10,350 | $10,110 | $10,430 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 0 | 200 | 190 | 190 | 220 |
| TOTAL | $N/A | $200 | $190 | $190 | $220 |
| Total Assets | $N/A | $11,380 | $11,330 | $10,970 | $11,370 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 1,420 | 1,450 | 1,120 | 1,180 |
| Accrued Expenses | N/A | 0 | 0 | 0 | 70 |
| Other current liabilities | N/A | 170 | 170 | 170 | 170 |
| TOTAL | $N/A | $1,610 | $1,640 | $1,310 | $1,440 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 270 | 260 | 250 | 260 |
| TOTAL | $N/A | $270 | $260 | $250 | $260 |
| Total Liabilities | $N/A | $1,880 | $1,910 | $1,570 | $1,700 |
| Shareholders' Equity | |||||
| Common Shares | N/A | 4 | 5 | 5 | 0 |
| Retained earnings | N/A | 7,680 | 7,600 | 7,530 | 7,660 |
| Other shareholders' equity | 0 | 86 | 85 | 135 | 280 |
| TOTAL | $N/A | $9,500 | $9,420 | $9,400 | $9,670 |
| Total Liabilities And Equity | $0 | $11,380 | $11,330 | $10,970 | $11,370 |